abstract |
THE PREPARATION OF COMPOUNDS OF FORMULA (I) IS DESCRIBED: AND PHARMACEUTICALLY ACCEPTABLE SALTS, IN WHICH R1 IS HYDROGEN OR METHYL; R2 IS HYDROGEN OR METHYL; ,- AND ,----- REPRESENT SINGLE OR DOUBLE BONDS; AND THE BENZENE RING IS REPLACED IN POSITION FOR OR GOAL. THESE COMPOUNDS HAVE INOTROPIC AND VASODILATOR PROPERTIES. PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE ARE DESCRIBED. |